Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 06/19/2015 - 04/22/2018

Target Audience

This course is designed for pharmacists, nurse practitioners or other healthcare professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

This session will provide an overview of the psychosis risk syndrome, describe initiatives and emerging data on the risk for psychosis, and discuss potential treatment strategies to prevent conversion to psychosis. Dr. Diana Perkins will share her expertise in early detection of psychosis and her insight as Principal Investigator of the NIMH funded “North American Prodrome Longitudinal Study” (NAPLS2), a large multisite grant from NIMH that aims to better understand the neurobiology of early course schizophrenia and to improve psychosis risk prediction.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Learning Objectives

  1. Understand the concept of the psychosis risk syndrome (schizophrenia prodrome) and discuss the major initiatives in the US and globally to characterize those with the risk syndrome (prodrome).
  2. Describe emerging data on understanding psychosis risk such as clinical and biological features that aid in detecting and identifying who may be at risk for developing psychosis.
  3. Review potential pharmacologic and psychosocial strategies that have been used in the prodrome and rationale for treatment.

Continuing Education Credit and Disclosures

Activity Dates: 06/19/2015 - 04/22/2018
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-15-023-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.10 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0000-15-023-H01-P (1.0 contact hours).